Two mouse hybridoma cell lines cultured in different basal media with the iron-rich protein-free supplement were subjected to deliberate starvation by inoculation into media diluted with saline to 50% or less. In the diluted media the growth was markedly suppressed and a large fraction of cells died by apoptosis. The cells could be rescued from apoptotic death by individual additions of amino acids, such as glycine, L-alanine, L-serine, L-threonine, L-proline, L-asparagine, L-glutamine, L-histidine, D-serine, β-alanine or taurine. Amino acids with hydrophobic or charged side chains were without effect. The apoptosis preventing activity manifested itself even in extremely diluted media, down to 10% of the standard medium. The activity of L-alanine in the protection of cells starving in 20% medium was shown also in semicontinuous culture. In the presence of 2 mM L-alanine the steady-state viable cell density more than doubled, with respect to control, and the apoptotic index dropped from 37% in the control to 16%. It was concluded that the apoptosis-preventing amino acids acted as signal molecules, rather than nutrients, and that the signal had a character of a survival factor. The specificity of present results, obtained with two different hybridomas, supports our view (Franěk and Chládková-Šrámková, 1995) that the membrane transport macromolecules themselves may play the role of the recognition elements in a signal transduction pathway controlling the survival of hybridoma cells.

Institute of Molecular Genetics Academy of Sciences of the Czech Republic Prague Czech Republic

Zobrazit více v PubMed

J Biol Chem. 1977 Apr 25;252(8):2680-3 PubMed

J Immunol Methods. 1983 Dec 16;65(1-2):55-63 PubMed

Cytotechnology. 1992;9(1-3):117-23 PubMed

Cytotechnology. 1991 Sep;7(1):33-8 PubMed

J Biol Chem. 1982 Mar 25;257(6):2974-80 PubMed

J Biol Chem. 1967 Nov 25;242(22):5237-46 PubMed

Cytotechnology. 1995 Jan;18(1-2):113-7 PubMed

Science. 1993 Oct 29;262(5134):695-700 PubMed

Biochim Biophys Acta. 1983 May 24;737(2):267-84 PubMed

Cytotechnology. 1990 Jul;4(1):13-28 PubMed

Science. 1959 Aug 21;130(3373):432-7 PubMed

Biotechnol Bioeng. 1995 Jan 5;45(1):86-90 PubMed

Nature. 1992 Apr 2;356(6368):397-400 PubMed

Cell. 1993 Sep 10;74(5):777-9 PubMed

Biotechnol Bioeng. 1994 Nov 5;44(9):1099-106 PubMed

J Cell Biol. 1970 Nov 1;47(2):453-9 PubMed

J Biol Chem. 1980 May 10;255(9):4011-9 PubMed

FASEB J. 1994 Jan;8(1):13-9 PubMed

J Cell Physiol. 1976 May;88(1):77-87 PubMed

J Exp Med. 1962 Jul 1;116:29-43 PubMed

Biotechnol Bioeng. 1994 Nov 5;44(9):1140-54 PubMed

Biotechnol Bioeng. 1993 Jun 20;42(2):185-95 PubMed

J Biol Chem. 1993 Jul 25;268(21):15351-5 PubMed

FEBS Lett. 1991 Jun 24;284(2):285-7 PubMed

Immunol Lett. 1993 Jan;35(1):19-24 PubMed

Biotechnol Bioeng. 1994 Sep 5;44(6):720-6 PubMed

Diverse effects of the cyclin-dependent kinase inhibitor bohemine: Concentration- and time-dependent suppression or stimulation of hybridoma culture

Modulation of cell cycle progression and of antibody production in mouse hybridomas by a nucleotide analogue